The chemokines which act through CXCR1 and CXCR2 participate in numerous cancer processes [7], and therefore CXCR1/2 inhibitors [307,308,309] as well as CXCR2 inhibitors [310], are considered as potential anticancer drugs. Here, CXCR1 is linked to cancer.